TL;DR
Mounjaro is FDA-approved for type 2 diabetes (not weight loss). If you want a tirzepatide formulation with an on-label weight-loss indication, or a more affordable alternative, several options exist.
Why people look for Mounjaro alternatives
Before evaluating alternatives, it helps to identify which pain is driving the search — different switching reasons point to different replacements.
Want on-label weight-loss
Mounjaro is approved for diabetes. Zepbound is the SAME drug (tirzepatide) marketed specifically for weight loss — insurance often covers Zepbound for that use.
Cost without insurance
Mounjaro's cash price is ~$1,069/mo. Compounded tirzepatide via telehealth runs $200-450/mo.
Switched provider needs
Some providers prefer prescribing semaglutide (Ozempic/Wegovy) over tirzepatide depending on clinical preference and side-effect history.
Lower side effects
Tirzepatide causes more nausea than semaglutide in some patients. Semaglutide-based alternatives may be more tolerable.
At-a-glance comparison
5 alternatives to Mounjaro, ordered by how often they’re chosen as direct replacements.
| Alternative | Best for | Type |
|---|---|---|
| Zepbound → | Patients wanting tirzepatide with weight-loss insurance coverage. | FDA brand |
| Compounded tirzepatide → | Cost-sensitive patients who don't need brand assurance. | Compounded |
| Ozempic → | Diabetic patients with tirzepatide intolerance. | FDA brand |
| Wegovy → | Patients who want semaglutide with weight-loss indication. | FDA brand |
| Compounded semaglutide → | Cost-sensitive patients who want any effective GLP-1. | Compounded |
Detailed breakdown of each alternative
1. Zepbound
FDA brandSame active ingredient (tirzepatide) but FDA-approved for weight loss — insurance covers it for that use.
- Best for
- Patients wanting tirzepatide with weight-loss insurance coverage.
- Honest limitation
- Off-label for diabetes (covered for weight loss only).
2. Compounded tirzepatide
CompoundedSame active ingredient at 50-70% lower cost via telehealth.
- Best for
- Cost-sensitive patients who don't need brand assurance.
- Honest limitation
- Not FDA-approved as a finished product.
3. Ozempic
FDA brandSemaglutide-based alternative for diabetes — different molecule, often better tolerated.
- Best for
- Diabetic patients with tirzepatide intolerance.
- Honest limitation
- Smaller average weight loss than tirzepatide.
4. Wegovy
FDA brandSemaglutide for weight loss — older molecule with more long-term data.
- Best for
- Patients who want semaglutide with weight-loss indication.
- Honest limitation
- Lower average efficacy than tirzepatide.
5. Compounded semaglutide
CompoundedCheapest GLP-1 option — semaglutide via telehealth at $150-300/mo.
- Best for
- Cost-sensitive patients who want any effective GLP-1.
- Honest limitation
- Not FDA-approved as a finished product.
Quick pick: which alternative for which goal
Same data, narrowed to a single recommendation per common goal. Use this when you already know what matters most.
If you want
Tirzepatide intolerance
Our pick
Wegovy →Semaglutide is often better tolerated; weight-loss approved.
When to stay with Mounjaro
Switching isn’t always the right answer. If your current setup meets your needs on cost, coverage, and outcomes, the friction of switching may not be worth it. Read our full Mounjaro review to confirm whether the issues you’re hitting are addressable without changing medications.
FAQ — Mounjaro alternatives
Is Mounjaro the same as Zepbound?
Yes — Mounjaro and Zepbound contain the same active ingredient (tirzepatide) in identical dose strengths. The difference is regulatory: Mounjaro is approved for type 2 diabetes, Zepbound for chronic weight management. Insurance coverage typically follows the indication on your prescription.
What is cheaper than Mounjaro?
Compounded tirzepatide via telehealth providers runs $200-450/mo — about half to a third of brand Mounjaro's $1,069 list price. Compounded products use the same active ingredient but are NOT FDA-approved as finished products.
Editorial summary based on published clinical data, provider websites, and public pricing. GLP1Zoom earns affiliate commissions when readers visit partner websites; this does not influence ranking decisions on this page. Full affiliate disclosure. Medical disclaimer.